Athersys
Therapeutic products for the treatment of several disease indications.
Launch date
Employees
Market cap
€426k
Enterprise valuation
€16m (Public information from Jan 2024)
Share price
$0 ATHX
Cleveland United States (HQ)
Authorizing premium user...